Global Cord Blood Corporation
CORBF
$1.02
-$0.13-11.30%
| 03/31/2022 | 09/30/2021 | 03/31/2021 | 12/31/2020 | ||
|---|---|---|---|---|---|
| Revenue | 0.41% | 17.39% | 8.52% | -7.59% | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | 0.41% | 17.39% | 8.52% | -7.59% | |
| Cost of Revenue | -6.61% | 10.51% | 13.72% | -7.50% | |
| Gross Profit | 1.66% | 18.67% | 7.64% | -7.61% | |
| SG&A Expenses | 7.73% | 12.02% | 6.81% | -2.97% | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | 2.79% | 11.83% | 10.17% | -2.42% | |
| Operating Income | -2.07% | 23.24% | 6.86% | -13.75% | |
| Income Before Tax | -7.54% | 7.01% | 24.81% | -13.71% | |
| Income Tax Expenses | 39.16% | 31.93% | -22.42% | -11.98% | |
| Earnings from Continuing Operations | -16.29% | 2.74% | 40.88% | -14.01% | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | 17.15% | -36.19% | -7.96% | -46.28% | |
| Net Income | -16.27% | 2.26% | 41.75% | -14.49% | |
| EBIT | -2.07% | 23.24% | 6.86% | -13.75% | |
| EBITDA | -1.94% | 21.90% | 6.86% | -12.63% | |
| EPS Basic | -16.36% | 2.30% | 41.36% | -14.21% | |
| Normalized Basic EPS | -0.97% | 19.71% | 8.55% | -- | |
| EPS Diluted | -16.45% | 1.99% | 41.47% | -14.21% | |
| Normalized Diluted EPS | -0.97% | 19.71% | 8.55% | -- | |
| Average Basic Shares Outstanding | 0.09% | 0.00% | 0.32% | -0.35% | |
| Average Diluted Shares Outstanding | 0.09% | 0.00% | 0.32% | -0.35% | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |
